Stay updated on Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page history now shows Revision: v3.5.5 as the latest version, replacing the previous v3.5.4.
    Difference
    0.0%
    Check dated 2026-06-05T13:41:43.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.4, indicating the site was updated to a newer release.
    Difference
    0.0%
    Check dated 2026-05-15T02:24:56.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.3, has been added to the history and the previous entry, v3.5.2, has been removed, updating the record of the page revisions.
    Difference
    0.0%
    Check dated 2026-04-30T16:41:00.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:44:23.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision history updated to include Revision: v3.5.0 and remove Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T17:45:54.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 in the page footer.
    Difference
    0.0%
    Check dated 2026-03-11T12:56:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.